Finance

Lists
Why is BBIO down 2.20%?
Dive Deeper
BBIO:NASDAQ
BridgeBio Pharma Inc
$ 65.04
-2.20%
(-1.46) 1D
$ 65.04
0.00% (0.00)
After hours
Closed: 10-р сарын 8, 16:00:01 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for BBIO...
Open
$ 66.39
High
$ 66.40
Low
$ 63.70
Mkt. cap
12.71 тэрбум
Avg. vol.
2.64 сая
Volume
3.36 сая
52-wk high
$ 93.42
52-wk low
$ 52.75
EPS
-$ 3.57
Beta
0.97
Shares outstanding
195.49 сая
No. of employees
1 мян.
Open
$ 66.39
High
$ 66.40
Low
$ 63.70
Mkt. cap
12.71 тэрбум
Avg. vol.
2.64 сая
Volume
3.36 сая
52-wk high
$ 93.42
52-wk low
$ 52.75
EPS
-$ 3.57
Beta
0.97
Shares outstanding
195.49 сая
No. of employees
1 мян.
News stories
From web sources and news partners
About BridgeBio Pharma Inc
CEONeil Kumar
Employees1 мян.
Founded2015
HeadquartersPalo Alto, Калифорни, Америкийн Нэгдсэн Улс
Sector-
Analyst ratings
Based on 17 analysts giving stock ratings to BBIO in the past 3 months
Strong buy
Buy
16
Hold
1
Sell
0
12-month forecast
Based on 17 Wall Street analysts offering 12 month price targets for BBIO in the last 3 months.
Highest
Current $ 65.04
$ 156.00 (+139.85%)
Average
$ 111.38 (+71.25%)
Lowest
$ 94.00 (+44.53%)
Analyst
Recommendation
Action
Price target
Projected
Date
Luca Issi
RBC Capital
Buy
Maintained
$ 100.00
+53.8%
10/08/2026
Whitney Ijem
Canaccord Genuity
Buy
Maintained
$ 106.00
+63%
10/06/2026
Jason Zemansky
Bank of America Securities
Buy
Maintained
$ 104.00
+59.9%
10/06/2026
Eliana Merle
Barclays
Buy
Maintained
$ 156.00
+139.9%
10/07/2026
Myles Minter
William Blair
Buy
Reiterated
-
-
10/06/2026
Ram Selvaraju
H.C. Wainwright
Buy
Reiterated
$ 120.00
+84.5%
10/06/2026
Tyler Van Buren
TD Cowen
Buy
Reiterated
$ 110.00
+69.1%
09/24/2026
Cory Kasimov
Evercore ISI
Buy
Maintained
$ 130.00
+99.9%
09/14/2026
Salim Syed
Mizuho Securities
Buy
Maintained
$ 110.00
+69.1%
08/31/2026
Andrew Tsai
Jefferies
Buy
Maintained
$ 110.00
+69.1%
08/31/2026
Biren Amin
Piper Sandler
Buy
Maintained
$ 115.00
+76.8%
08/31/2026
Joshua Schimmer
Cantor Fitzgerald
Buy
Maintained
$ 110.00
+69.1%
08/29/2026
Eric Joseph
Citi
Hold
Maintained
$ 94.00
+44.5%
08/12/2026
Anupam Rama
J.P. Morgan
Buy
Reiterated
$ 111.00
+70.7%
08/12/2026
Danielle Brill
Truist Financial
Buy
Maintained
$ 107.00
+64.5%
08/12/2026
Sean Laaman
Morgan Stanley
Buy
Reiterated
$ 97.00
+49.1%
08/11/2026
Derek Archila
Wells Fargo
Buy
Reiterated
$ 102.00
+56.8%
08/11/2026
Unknown Analyst
Wells Fargo
Buy
Reiterated
$ 102.00
+56.8%
08/11/2026
Tiago Fauth
Raymond James
Buy
Maintained
$ 98.00
+50.7%
06/17/2026
Martin Auster
Raymond James
Hold
Downgraded
-
-
05/26/2026
Unknown Analyst
Citi
Hold
Initiated
-
-
05/19/2026
William Pickering
Bernstein
Buy
Reiterated
$ 114.00
+75.3%
05/08/2026
Paul Choi
Goldman Sachs
Buy
Maintained
$ 116.00
+78.4%
05/08/2026
Matt Phipps
William Blair
Buy
Reiterated
-
-
05/02/2026
Lisa Walter
RBC Capital
Buy
Initiated
$ 100.00
+53.8%
04/08/2026
Trevor Allred
Oppenheimer
Buy
Maintained
$ 81.00
+24.5%
02/25/2026
Last report
2026 оны 8-р сарын 10
Fiscal period
Q2 2026
-$ 0.78 / -$ 0.58
-33.87%miss
Revenue / Est. (USD)
243.68 сая / 219.71 сая
+10.91%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
120.70 сая
154.18 сая
194.52 сая
243.68 сая
Cost of goods sold
6.56 сая
8.11 сая
9.94 сая
15.05 сая
Cost of revenue
6.56 сая
8.11 сая
9.94 сая
15.05 сая
Research and development expenses
112.87 сая
116.42 сая
126.64 сая
149.45 сая
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
137.62 сая
158.08 сая
163.90 сая
186.26 сая
Operating expense
250.50 сая
274.50 сая
290.53 сая
335.71 сая
Total operating expenses
257.06 сая
282.61 сая
300.47 сая
350.76 сая
Operating income
-136.36 сая
-128.43 сая
-105.96 сая
-107.08 сая
Other non operating income
16.46 сая
11.82 сая
4.25 сая
5.59 сая
EBT including unusual items
-186.48 сая
-194.76 сая
-166.56 сая
-155.89 сая
EBT excluding unusual items
-177.64 сая
-183.62 сая
-166.56 сая
-155.89 сая
Income tax expense
-1.54 сая
-120.00 мян
-
-
Effective tax rate
0.83%
0.06%
-
-
Other operating expenses
-
-
-
-
Net income
-182.74 сая
-192.86 сая
-164.04 сая
-152.22 сая
Net profit margin
-151.40%
-125.09%
-84.33%
-62.47%
Earnings per share
-0.72
-0.94
-0.84
-0.78
Interest and investment income
6.24 сая
4.33 сая
6.25 сая
6.66 сая
Interest expense
-48.15 сая
-50.31 сая
-52.82 сая
-54.62 сая
Net interest expenses
-41.91 сая
-45.98 сая
-46.57 сая
-47.96 сая
Depreciation and amortization charges
-
-
-
-
EBITDA
-134.96 сая
-127.00 сая
-104.77 сая
-106.03 сая
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google аппс